Cargando…
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study
INTRODUCTION: In the real-world APPRECIATE study (NCT02740218), most patients with psoriasis demonstrated notable improvements on disease severity measures and reported clinically meaningful treatment benefits with apremilast. OBJECTIVE: We aim to further describe patient-relevant needs and benefits...
Autores principales: | Klein, Toni Maria, Blome, Christine, Kleyn, C. Elise, Conrad, Curdin, Sator, Paul G., Ståhle, Mona, Eyerich, Kilian, Radtke, Marc Alexander, Bundy, Christine, Cordey, Myriam, Griffiths, Christopher E. M., Augustin, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776914/ https://www.ncbi.nlm.nih.gov/pubmed/34813044 http://dx.doi.org/10.1007/s13555-021-00628-3 |
Ejemplares similares
-
Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study
por: Jonak, Constanze, et al.
Publicado: (2023) -
How do dermatologists’ personal models inform a patient‐centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)
por: Hewitt, Rachael M., et al.
Publicado: (2022) -
Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink
por: Persson, Rebecca, et al.
Publicado: (2022) -
Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe
por: Cetkovská, Petra, et al.
Publicado: (2023) -
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
por: Das, Ashis K., et al.
Publicado: (2023)